Kwangho Lee Selected Research

Kwangho Lee Research Topics

11	Neoplasms (Cancer) 01/2022 - 12/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2013
3	Body Weight (Weight, Body) 06/2015 - 06/2014
2	Aortic Dissection 02/2022 - 12/2016
2	Heart Failure 10/2020 - 04/2009
2	Aneurysm (Aneurysms) 03/2018 - 12/2016
2	Intracranial Aneurysm (Cerebral Aneurysm) 03/2018 - 12/2016
2	Autoimmune Diseases (Autoimmune Disease) 10/2017 - 01/2016
1	Pica (Geophagia) 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Burns 12/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2020
1	Cardiogenic Shock 10/2020
1	Liver Neoplasms (Liver Cancer) 11/2019
1	Thrombosis (Thrombus) 03/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2018
1	Rupture 03/2018
1	Hemorrhage 03/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Lung Neoplasms (Lung Cancer) 07/2017
1	Plexiform Neurofibroma 09/2014
1	Myocarditis (Carditis) 05/2012
1	Clostridium Infections 03/2012
1	Muscular Dystrophies (Muscular Dystrophy) 12/2010
1	Pulmonary Hypertension 06/2009
1	Death (Near-Death Experience) 04/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2009
1	Hyperemia 09/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2006
1	Orthostatic Hypotension (Postural Hypotension) 02/2006
1	Obesity 06/2005
1	Cardiomegaly (Heart Hypertrophy) 06/2005

3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2013
3	Pharmaceutical PreparationsIBA 11/2017 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 08/2015
2	1,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanoneIBA 10/2020 - 08/2015
2	Tyrosine Kinase InhibitorsIBA 12/2015 - 12/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	NucleophosminIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Tirofiban (Aggrastat)FDA Link 03/2018
1	Glycoproteins (Glycoprotein)IBA 03/2018
1	IndazolesIBA 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	LigandsIBA 12/2017
1	QuinoxalinesIBA 10/2017
1	lorlatinibIBA 07/2017
1	Anaplastic Lymphoma KinaseIBA 07/2017
1	Phosphotransferases (Kinase)IBA 07/2017
1	Death-Associated Protein KinasesIBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	CrizotinibIBA 08/2015
1	Bee Venoms (Bee Venom)IBA 09/2014
1	Gefitinib (Iressa)FDA Link 06/2014
1	Hematoxylin (Haematoxylon)IBA 06/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2014
1	alkoxyl radicalIBA 01/2014
1	PyrimidinesIBA 01/2014
1	TriazinesIBA 01/2014
1	rociletinibIBA 12/2013
1	TenascinIBA 05/2012
1	LFF571IBA 03/2012
1	Natriuretic PeptidesIBA 12/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2009
1	Adenosine Triphosphate (ATP)IBA 09/2008
1	Vasoconstrictor AgentsIBA 02/2006
1	LeptinIBA 06/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2005

4	Stents 02/2022 - 12/2016
1	Semiconductors 12/2020
1	Extracorporeal Membrane Oxygenation 10/2020
1	Catheters 03/2018
1	Intramuscular Injections 06/2015
1	Intravenous Injections 09/2014
1	Oral Administration 12/2013
1	Patient Readmission 04/2009
1	Intravenous Infusions 09/2008